Biomaterial Database

Molecular and thermodynamic aspects of solubility advantage from solid dispersions. 2007

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab 160 062, India. akbansal@niper.ac.in

The solubility behavior of solid dispersions of two drugs with similar structures was studied. Valdecoxib (VLB) and etoricoxib (ETB) were used as model drugs, and their solid dispersions were prepared with 1, 2, 5, 10, 15, and 20% w/w poly(vinylpyrrolidone) (PVP) by the quench cooling method. The interactions between the drug and polymer molecules were studied by Fourier transform infrared spectroscopy (FT-IR). The thermodynamic aspects of solubility behavior were studied by plotting van't Hoff plots. Both the drugs showed significant differences in their solubility behavior. In the case of VLB, solubility was found to increase significantly with increasing PVP concentration. ETB however did not show any significant solubility enhancement and was found to have decreased solubility at high PVP concentrations. H-bonding interactions were established between VLB and PVP molecules, while none were observed in ETB-PVP dispersions. Solution thermodynamics of amorphous and crystalline forms of both the drugs were studied by van't Hoff plots. The results obtained showed very high negative value of Gibbs free energy for VLB as compared to ETB, thus demonstrating high spontaneity of VLB solubilization. Entropy of amorphous VLB was found to be highly favorable, while being slightly unfavorable for ETB. From this study H-bonding interactions were found to play a major role in dictating the solubility behavior of these drugs from solid dispersions.

UI	MeSH Term	Description	Entries
D007555	Isoxazoles	Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.	Isoxazole
D011725	Pyridines	Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D000077613	Etoricoxib	A sulfone and pyridine derivative that acts as a cyclooxygenase-2 inhibitor. It is used as a NSAID for the treatment of pain associated with RHEUMATOID ARTHRITIS and ANKYLOSING SPONDYLITIS. It is also used for the short-term treatment of moderate postoperative dental pain.	Arcoxia,L-791456,MK 0663,MK-0663,L 791456,L791456,MK0663
D012995	Solubility	The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)	Solubilities
D013449	Sulfonamides	A group of compounds that contain the structure SO2NH2.	Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013450	Sulfones		Sulfone
D013816	Thermodynamics	A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed)	Thermodynamic
D015394	Molecular Structure	The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.	Structure, Molecular,Molecular Structures,Structures, Molecular
D017550	Spectroscopy, Fourier Transform Infrared	A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained.	FTIR,Fourier Transform Infrared Spectroscopy,Spectroscopy, Infrared, Fourier Transform

Related Publications

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Solubility advantage from amorphous etoricoxib solid dispersions.

January 2014, Drug development and industrial pharmacy,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions.

December 2016, Journal of pharmaceutical sciences,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Solubility Advantage of Amorphous Ketoprofen. Thermodynamic and Kinetic Aspects by Molecular Dynamics and Free Energy Approaches.

July 2020, Journal of chemical theory and computation,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.

January 2004, Molecular pharmaceutics,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.

October 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

API solubility in semi-crystalline polymer: Kinetic and thermodynamic phase behavior of PVA-based solid dispersions.

July 2022, International journal of pharmaceutics,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Experimental, Thermodynamic, and Molecular Modeling Evaluation of Amorphous Simvastatin-Poly(vinylpyrrolidone) Solid Dispersions.

July 2020, Molecular pharmaceutics,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.

March 2010, Journal of pharmaceutical sciences,

Shyam Sunder Bansal, and Aditya Mohan Kaushal, and Arvind Kumar Bansal

Solubility of solid dispersions of pizotifen malate and povidone.

July 2001, Drug development and industrial pharmacy,